At Purrtein we are committed to science, life and the future. That is why we are constantly evolving and wish to continue growing and innovating our human, animal and plant health solutions.
To achieve this, we seek strategic collaborations with other companies or institutions that share our same philosophy in order to develop new businesses and products.
We seek licenses for pharmaceuticals and other third party products in order to expand and strengthen our portfolio.
We also want to expand our international presence and therefore we seek alliances with partners to operate in new countries, either to market our products or to develop and/ or market launch our R+D projects.
We have fully qualified facilities for the development, and even manufacturing, of active ingredients and other compounds extracted from raw materials of biologically-derived origin.
Purrtein has begun innovation partnership with Universitas Diponegoro. The goal is to to develop the potential application of fish protein hydrolyzate as a ready-to-eat dry noodle ingredient for children's growth and development.
Purrtein has begun innovation partnership with Universitas Pasundan. The goal is to encapsule and concentrate purrtein fish oil in a way that sustains all ingredients.
Purrtein has begun innovation partnership with Agriterra. The goal of this partnership is to build supply chain of fish protein hydrolysate by developing several integrated manufacturer in the strategic location.
Purrtein has begun innovation partnership with Universitas Padjajaran. The goal of this partnership is to ascertain how biostimulant fish protein hydrolysate affects on plants.
Purrtein has begun innovation partnership with Mina Bahari Cooperatives. Mina Bahari is the local enterprise that oversees local fisherman to managing their catches and revive the blue economy.
We are proactive in forming strategic alliances with public and private research centres, hospitals, academic institutions and other businesses around the world to develop new products
Exercitation ullamco laboris nis aliquip sed conseqrure dolorn repreh deris ptate velit ecepteur duis.